SCHEMBL5460108

SCHEMBL5460108

NC(=O)c1c(NC(=O)CC2CC2)sc2c1CCOC2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 1/20 0.56
▸ PTPRC P08575 1/20 0.51
▸ PTPN2 P17706 1/20 0.51
▸ PTPN1 P18031 1/20 0.51
▸ PTPRB P23467 1/20 0.51
▸ PTPRE P23469 1/20 0.51
▸ ALDH1A1 P00352 7/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ HPGD P15428 3/20 0.49
▸ TSHR P16473 3/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ MAPK10 P53779 2/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ AIP O00170 1/20 0.49
▸ SGTA O43765 1/20 0.49
▸ TOMM70 O94826 1/20 0.49
▸ STIP1 P31948 1/20 0.49
▸ PPP5C P53041 1/20 0.49
▸ DNAJC7 Q99615 1/20 0.49
▸ STUB1 Q9UNE7 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5455169 0.95 CFTR (0.54) CFTRPTPRCPTPN2PTPN1PTPRB
SCHEMBL5460509 0.90 CFTR (0.53) CFTRPTPRCPTPN2PTPN1PTPRB
SCHEMBL5445049 0.84 CFTR (0.60) CFTRPTPRCPTPN2PTPN1PTPRB
SCHEMBL5460139 0.84 CFTR (0.60) CFTRPTPRCPTPN2PTPN1PTPRB
SCHEMBL5451681 0.84 CFTR (0.54) CFTRPTPRCPTPN2PTPN1PTPRB
SCHEMBL5460260 0.83 CNR2 (0.54) CFTRPTPRCPTPN2PTPN1PTPRB
SCHEMBL5444948 0.83 FLT3 (0.70) CFTRPTPRCPTPN2PTPN1PTPRB
SCHEMBL5451710 0.82 CFTR (0.58) CFTRPTPRCPTPN2PTPN1PTPRB
SCHEMBL5449075 0.82 CFTR (0.66) CFTRPTPRCPTPN2PTPN1PTPRB
SCHEMBL5453289 0.82 LMNA (0.59) CFTRPTPRCPTPN2PTPN1PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 — — US claimed
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents TBCA, PARK7, NFATC1 CFTR 2030/4885PTPRC 1457/4885PTPN2 2364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback